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ABSTRACT 
 
Necrotizing enterocolitis (NE) is inflammatory disease and its prevalence was in-
crease in preterm and low birth weight (LBW) neonates. This study was aimed to 
investigate the differences of fecal calprotectin level in breast milk-formula vs 
formula feeding infants in preterm and low birth weight neonates with necrotizing 
enterocolitis. There are 32 preterm and LBW neonates with NE were divided into 
two group (breast milk-formula and formula only feeding group). Fecal calprotec-
tin level was measured using ELISA method. This study showed that fecal calpro-
tectin level in breast milk-formula feeding group was insignificantly lower as 
compared to formula feeding group (independent t-test, p = 0.503). Further anal-
ysis showed that fecal calprotectin level was negatively correlated with patient’s 
outcome (Spearman correlation test, p = 0.03, r = 0.512). We concluded that fecal 
calprotectin level in breast milk-formula feeding group was insignificantly lower 
as compared to formula feeding only group in preterm and low birth weight neo-
nates diagnosed with necrotizing enterocolitis. There was negative correlation be-
tween fecal calprotectin level and patient’s outcome. 
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Introduction 
Necrotizing enterocolitis is one of emergency 
case in neonates, especially in new born with low 
birth weight [1, 2]. The incidence of necrotizing 
enterocolitis is ranged 1 – 5% among 1000 birth 
rate and increase up to 5 – 10% in very low birth 
weight neonates. Mortality rate of necrotizing en-
terocolitis is 20 – 50% [3,4]. The main risk factor 
of necrotizing enterocolitis is prematurity and low 
birth weight [3, 4]. The others risk factor of ne-
crotizing enterocolitis are administration of enteral 
nutrition, bacterial colonization, erythrocyte trans-
fusion, prolonged utilization of mechanical venti-
lator or other ventilation support device [5, 6]. 
Several studies had been demonstrated the under-
lying mechanism of necrotizing enterocolitis such 
as intestinal ischemia, bacterial translocation, sep-
ticemia and organ dysfunction [5, 6, 7].  
Because of unclear understanding about etio- 
logic and pathogenesis of necrotizing enterocol-
itis, the morbidity and mortality of this disease is 
still high [8]. Recently, there was no consensus 
concerns about the management of enteral nutri-
tion in order to prevent necrotizing enterocolitis 
based on time, volume, and type [9]. Breastfeed-
ing had been associated with decreased incidence 
of necrotizing enterocolitis in preterm neonates 
[10]. Otherwise, formula feeding was risk factor 
for developing necrotizing enterocolitis because of 
its high fatty acid contents which had toxic effect 
on cells [10].   
Many biomarkers had been studied which rep-
resented the severity of this disease such as serum 
amyloid A (SAA), anaphylatoxin (C5a), urinary 
intestinal fatty acid binding protein (I-FABP), 
claudin-3, fecal platelet-activating factor (PAF), 
calprotectin, inter-a-inhibitory protein (IaIp), C-
reactive protein, and citrulline [11, 12, 13]. Cal- 
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protectin is peptide which represented local in-
flammation and apoptosis [14]. Fecal calprotectin 
had been used as screening tool for intestinal in-
flammation disease [15]. In certain condition, fe-
cal calprotectin could be used as necrotizing enter-
ocolitis biomarker if its concentrations raised up to 
350 µg/g following with intestinal perforation, 
bloody fecal, and other clinical manifestation rep-
resenting intestinal injury [16]. This study was 
aimed to investigate the differences of fecal cal-
protectin level in breast milk-formula vs formula 
feeding infants in preterm and low birth weight ne-
onates with necrotizing enterocolitis. 
 
Material and Methods 
Study design 
This study was cross-sectionally designed to 
compare fecal calprotectin level of breast milk-
formula feeding vs formula feeding group in pre-
term and low birth weight neonates with necrotiz-
ing enterocolitis. This study was conducted in ne-
onatology ward of Pediatric Department, Dr. Sai-
ful Anwar Hospital Malang, and Biochemistry La-
boratory, Faculty of Medicine, Brawijaya Univer-
sity Malang. This study had been approved by Eth-
ical Committee of Saiful Anwar Hospital Malang, 
Indonesia. Preterm neonates are defined as neo-
nates which born at gestation week less than 37 
weeks. Low birth weight is defined as birth body 
weight less than 2,500 g. Necrotizing enterocolitis 
is diagnosed using clinical symptoms (abdominal 
distension and hematoschezia) and feature of in-
testinal pneumatosis in plain abdominal radio-
graph. Formula feeding used in this study was spe-
cific formula for low birth weight neonates con-
taining 80 kkal/100 mL calories, 2 g/100 mL pro-
tein, and optimal mineral composition for intrau-
terine requirements. 
 
Population and subject 
This study contained was sixteen subjects in 
each group. Inclusion criteria of subject were pre-
term and low birth weight neonates which had 
been diagnosed with necrotizing enterocolitis and 
hospitalized in Saiful Anwar Hospital, any mode 
of birth delivery (vaginal or abdominal delivery), 
allowed by his/her parents to join in this study (in-
formed consent). Exclusion criteria of subjects are 
preterm and low birth weight neonates which need 
surgical procedure and did not allowed by his/her 
parents to join in this study. 
 
Fecal sampling 
Fecal sample is obtained with qualified proce-
dure such as stored in special (maintain stable tem-
perature) and clean tube and immediately trans-
ported to the laboratory in less than 30 minutes (or 
could be stored at -20°C).   
 
Measurements of fecal calprotectin 
Before ELISA procedure performed, fecal 
sample should be homogenized and extracted us-
ing extraction buffer containing 0.1 M Tris, 0.15 
M NaCl, 1.0 M urea, 10 mM CaCl2, 0.1 M mono-
hydrate citric acid, 5 g/L BSA, 0.25 mM thimero-
sal (pH 8.0). as many as 5 mL extraction buffer is 
added for each 100 mg sample. After mixing with 
extraction buffer, sample is shaken for 20 minutes 
and then centrifuged at 4°C for 20 minutes. After 
centrifugation procedure, sample is ready for 
ELISA procedure. Basically, sample and calpro-
tectin standard are incubated in microplate which 
coated with specific antibody for calprotectin. An-
tibody is conjugated to streptavidin-peroxidase. 
Streptavidin peroxidase conjugation will react 
with tetra-methyl-benzidine substrate. This reac-
tion then will be stopped by addition of oxalic 
acid. Light absorbance is measured using spectro-
photometry at wavelength 450 nm. Calprotectin 
level is converted from absorbance value into con-
centration using calprotectin standard curve. 
 
Statistical analysis 
Distribution of data calprotectin level was an-
alyzed using Shapiro-Wilk test. Calprotectin level 
data in combined feeding group was compared to 
formula feeding only group using independent t-
test. Correlation of group and calprotectin level is 
analyzed using Pearson correlation test. If the data 
distribution is not normal, comparation and corre-
lation test will be performed using non-parametric 
test. All the test is performed at confidence inter-
val 95% using software SPSS version 17.0. 
 
Results and Discussion 
Characteristics of subjects 
This study involved 32 subjects divided into 
two groups: preterm and low birth weight neonates 
diagnosed with necrotizing enterocolitis which re-
ceive breast milk-formula feeding and formula 
feeding. The subject characteristic such as sex, 
age, gestational age, maternal risk factor, birth 
weight described in Table 1. Based on sex, data  
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showed that the number of male subject and fe-
male subject involved in this study was relatively 
same. This result was in accordance with previous 
study which showed that the incidence of necrotiz-
ing enterocolitis was 55% in male subjects and 
45% in female subject [8]. Necrotizing enterocol-
itis occurred earlier in formula feeding group com-
pared with breast milk-formula feeding group. 
Furthermore, Apgar score both in first and fifth 
minutes was lower in formula feeding group as 
compared to breast milk-formula feeding group. 
This result was in accordance with previous study 
which demonstrated that early onset necrotizing 
enterocolitis was associated with respiratory dis-
tress [17]. Ventilation support utilization showed 
no significant differences between groups. Previ-
ous study revealed that CPAP (continuous positive 
airway pressure) and mechanical ventilator utili-
zation was earlier in necrotizing enterocolitis 
group as compared to digestive distress group [18] 
Based on gestational age, there was no signif-
icant differences between breast milk-formula 
feeding group and formula feeding group. Further-
more, birth weight showed that in breast milk-for-
mula feeding group had no significant differences 
with formula feeding group. Another data also 
showed similar result in fetal growth status. Previ-
ous study had been demonstrated that mean of ges-
tational age 29 (ranged 23 – 33 weeks) was corre-
lated with elevated incidence of necrotizing enter-
ocolitis [17]. Previous study also showed that ne-
crotizing enterocolitis had been occurred in 50% 
and 30% in neonates with birth weight 1,000 – 
1,499 g and 1,500 – 1,999 g, respectively [19]. 
Similarly, 22 years retrospective study showed 
that the incidence of necrotizing enterocolitis 
mostly occurred in neonates with birth weight 
1,000 – 1,499 g [2]. Olariu and colleagues also 
showed that mean of birth weight in necrotizing 
enterocolitis group was 1078 ± 338.72 g [8]. Ba- 
Table 1. Characteristic of Subject 
Characteristic 
Group 1 Breast milk- 
formula feeding (n=16) 
Group 2 Formula feeding 
only (n=16) 
Total 
Sex    
Male  6/16 8/16 14 
Female   10/16 8/16 18 
Onset of NE (mean ± SD (day)) 9.31 ± 4.1 3.75 ± 1.6  
Gestational age (mean ± SD (week)) 34 ± 3.2 32.7 ± 2.9  
Birth weight (mean ± SD (g)) 1521.25 ± 381.87 1728.19 ± 444.38  
Fetal growth status    
AGA (Appropriate for Gestational Age)  11/16 15/16 26 
SGA (Small for Gestational Age) 5/16 1/16 6 
Place of birth    
Saiful Anwar Hospital 4/16 6/16 10 
Outside Saiful Anwar Hospital 12/16 10/16 22 
Apgar score    
First minute (mean ± SD) 5 ± 2 4.3 ± 2.02  
Fifth minute (mean ± SD) 6.6 ± 2.3 5.8 ± 2.5  
Mode of birth delivery    
Vaginal delivery 10/16 10/16 20 
Abdominal delivery 6/16 6/16 12 
Maternal risk factor    
Hypertension 0 1/16 1 
Eclampsia 2/16 0 2 
Preterm rupture of membrane  6/16 2/16 8 
Oxygenation     
Nasal cannula  9/16 5/16 15 
NCPAP (nasal continuous positive air-
way pressure) 
6/16 8/16 14 
Mechanical ventilator 1/16 3/16 4 
Outcome    
Alive 16/16 12/16 28 
Died 0 4/16 4 
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Figure 1. Mean of fecal calprotectin level (ng/mL) in 
breast milk-formula feeding group and for-
mula-feeding-only group of preterm and low 
birth weight neonates with necrotizing enter-
ocolitis  
 
sed on mode of birth delivery, there was no signif-
icant differences between groups. Otherwise, pre-
vious study showed that abdominal delivery was 
associated with increased incidence of necrotizing 
enterocolitis and might be caused by late coloni-
zation of normal flora in gastrointestinal tract [20]. 
Figure 1 showed fecal calprotectin level of 
combined feeding group and formula-feeding-
only group. Comparison test showed that there 
were no significant statistical differences between 
groups (independent t-test, p = 0.9). However, the 
level of fecal calprotectin in breast milk-formula 
feeding group (508.873 ng/mL) was lower as com-
pared to formula-feeding-only group (555.625 
ng/mL). Cut-off value for fecal calprotectin level 
for healthy term and preterm neonates was 145 
µg/g and 332 µg/g, respectively [21]. Several stud-
ies showed inconsistent finding regarding to cor-
relation of breastfeeding or formula feeding and 
fecal calprotectin level. Campeotto and Baldassare 
demonstrated that nutritional type was not associ-
ated with calprotectin level in term neonates [22]. 
Another study showed that calprotectin level was 
lower in breastfeeding group as compared to for-
mula feeding group [5]. Similarly, Good and col-
leagues revealed that the incidence of necrotizing 
enterocolitis was lower in high intake breastfeed-
ing > 50% (3%) as compared to low intake breast-
feeding (10%) [10]. Conversely, Dorosko and 
Savino showed that calprotectin level was ele-
vated in exclusive breastfeeding group as com-
pared to breast milk-formula and formula-feeding-
only group [21]. These controversial results might 
be caused by uncontrolled bias factor such as ges-
tational age, the amount of formula feeding which 
more than 50% breast milk thereby could affect 
calprotectin level. 
 
Correlation of fecal calprotectin level and out-
come 
Correlation study showed that fecal calprotec-
tin level was negatively correlated with patient’s 
outcome (Spearman correlation test, p = 0.03, r = 
0.512). It means that low fecal calprotectin level 
was correlated with high survival rate. Figure 2 
showed correlation graph of fecal calprotectin 
level and patient’s outcome. Several studies had 
been showed correlation of elevated fecal calpro-
tectin and patient’s outcome. Several studies re-
vealed that elevated fecal calprotectin could pre-
dict necrotizing enterocolitis [15, 22, 23]. Further-
more, in formula feeding group who died, cut-off 
value of mean fecal calprotectin level was 248.69 
ng/mL. This result was similar with previous study 
which showed that fecal calprotectin was rela-
tively low in fulminant necrotizing enterocolitis 
[18]. This condition might be caused by recruit-
ment impairment of granulocyte in intestinal lu-
men and impaired immune response [18]. Further 
analysis also confirmed that antimicrobial peptide 
concentration which possessed chemotactic factor 
for neutrophil was lower in preterm neonates [18].  
This study was designed as observational 
(cross-sectional) that has a limitation in investigat-
ing the causal effect. Because of that, we sug-
gested to do further research which developed ex-
perimentally both in vivo or in vitro to investigate 
the role of breast milk and formula feeding on fe-
cal calprotectin and clinical improvement of ne-
crotizing enterocolitis. Besides that, we suggested 
to investigate the role of fecal cytokines in preterm 
and low birth weight neonates with necrotizing en-
terocolitis and its correlation with breastfeeding. 
Fecal cytokines which could be detected in fecal 
sampling for example human β-defensin 2(hBD2). 
Other limitation of study was variation of fecal 
sampling since defecation process which could in-
fluence calprotectin level. 
 
Conclusion 
We concluded that fecal calprotectin level in 
breast milk-formula feeding group was insignifi-
cantly lower as compared to formula feeding only 
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group in preterm and low birth weight neonates di-
agnosed with necrotizing enterocolitis. There was 
negative correlation between fecal calprotectin 
level and patient’s outcome. 
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